» Articles » PMID: 26723900

TP53 and LacZ Mutagenesis Induced by 3-nitrobenzanthrone in Xpa-deficient Human TP53 Knock-in Mouse Embryo Fibroblasts

Overview
Publisher Elsevier
Date 2016 Jan 3
PMID 26723900
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

3-Nitrobenzanthrone (3-NBA) is a highly mutagenic compound and possible human carcinogen found in diesel exhaust. 3-NBA forms bulky DNA adducts following metabolic activation and induces predominantly G:CT:A transversions in a variety of experimental systems. Here we investigated the influence of nucleotide excision repair (NER) on 3-NBA-induced mutagenesis of the human tumour suppressor gene TP53 and the reporter gene lacZ. To this end we utilised Xpa -knockout (Xpa-Null) human TP53 knock-in (Hupki) embryo fibroblasts (HUFs). As Xpa is essential for NER of bulky DNA adducts, we hypothesized that DNA adducts induced by 3-NBA would persist in the genomes of Xpa-Null cells and lead to an increased frequency of mutation. The HUF immortalisation assay was used to select for cells harbouring TP53 mutations following mutagen exposure. We found that Xpa-Null Hupki mice and HUFs were more sensitive to 3-NBA treatment than their wild-type (Xpa-WT) counterparts. However, following 3-NBA treatment and immortalisation, a similar frequency of TP53-mutant clones arose from Xpa-WT and Xpa-Null HUF cultures. In cells from both Xpa genotypes G:CT:A transversion was the predominant TP53 mutation type and mutations exhibited bias towards the non-transcribed strand. Thirty-two percent of 3-NBA-induced TP53 mutations occurred at CpG sites, all of which are hotspots for mutation in smokers' lung cancer (codons 157, 158, 175, 245, 248, 273, 282). We also examined 3-NBA-induced mutagenesis of an integrated lacZ reporter gene in HUFs, where we again observed a similar mutant frequency in Xpa-WT and Xpa-Null cells. Our findings suggest that 3-NBA-DNA adducts may evade removal by global genomic NER; the persistence of 3-NBA adducts in DNA may be an important factor in its mutagenicity.

Citing Articles

Characterising Mutational Spectra of Carcinogens in the Tumour Suppressor Gene Using Human Knock-in (Hupki) Mouse Embryo Fibroblasts.

Holzl-Armstrong L, Kucab J, Korenjak M, Luijten M, Phillips D, Zavadil J Methods Protoc. 2019; 2(4).

PMID: 31766274 PMC: 6961128. DOI: 10.3390/mps2040085.


Kinetic Investigation of Translesion Synthesis across a 3-Nitrobenzanthrone-Derived DNA Lesion Catalyzed by Human DNA Polymerase Kappa.

Phi K, Smith M, Tokarsky E, Suo Z Chem Res Toxicol. 2019; 32(8):1699-1706.

PMID: 31286773 PMC: 7198833. DOI: 10.1021/acs.chemrestox.9b00219.


Role of Human Aldo-Keto Reductases in the Metabolic Activation of the Carcinogenic Air Pollutant 3-Nitrobenzanthrone.

Murray J, Mesaros C, Arlt V, Seidel A, Blair I, Penning T Chem Res Toxicol. 2018; 31(11):1277-1288.

PMID: 30406992 PMC: 6319660. DOI: 10.1021/acs.chemrestox.8b00250.


The impact of p53 function on the metabolic activation of the carcinogenic air pollutant 3-nitrobenzanthrone and its metabolites 3-aminobenzanthrone and N-hydroxy-3-aminobenzanthrone in human cells.

Wohak L, Baranski A, Krais A, Schmeiser H, Phillips D, Arlt V Mutagenesis. 2018; 33(4):311-321.

PMID: 30215795 PMC: 6180618. DOI: 10.1093/mutage/gey025.


Benchmark dose analyses of multiple genetic toxicity endpoints permit robust, cross-tissue comparisons of MutaMouse responses to orally delivered benzo[a]pyrene.

Long A, Wills J, Krolak D, Guo M, Dertinger S, Arlt V Arch Toxicol. 2017; 92(2):967-982.

PMID: 29177888 PMC: 5818629. DOI: 10.1007/s00204-017-2099-2.


References
1.
Kato S, Han S, Liu W, Otsuka K, Shibata H, Kanamaru R . Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci U S A. 2003; 100(14):8424-9. PMC: 166245. DOI: 10.1073/pnas.1431692100. View

2.
Benbrahim-Tallaa L, Baan R, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V . Carcinogenicity of diesel-engine and gasoline-engine exhausts and some nitroarenes. Lancet Oncol. 2012; 13(7):663-4. DOI: 10.1016/s1470-2045(12)70280-2. View

3.
Phillips D, Arlt V . The 32P-postlabeling assay for DNA adducts. Nat Protoc. 2007; 2(11):2772-81. DOI: 10.1038/nprot.2007.394. View

4.
Arlt V, Schmeiser H, Osborne M, Kawanishi M, Kanno T, Yagi T . Identification of three major DNA adducts formed by the carcinogenic air pollutant 3-nitrobenzanthrone in rat lung at the C8 and N2 position of guanine and at the N6 position of adenine. Int J Cancer. 2005; 118(9):2139-46. DOI: 10.1002/ijc.21622. View

5.
Reinbold M, Luo J, Nedelko T, Jerchow B, Murphy M, Whibley C . Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72. Oncogene. 2007; 27(19):2788-94. PMC: 6813802. DOI: 10.1038/sj.onc.1210932. View